Overview of Dr. Ahluwalia
Dr. Manmeet Ahluwalia is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami, Cleveland Clinic, and Cleveland Clinic Fairview Hospital. He received his medical degree from Maulana Azad Medical College and has been in practice 17 years. Dr. Ahluwalia accepts several types of health insurance, listed below. He is one of 188 doctors at Cleveland Clinic and one of 16 doctors at Cleveland Clinic Fairview Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
Baptist Health Miami Cancer Institute
8900 N Kendall Dr
Miami, FL 33176- Is this information wrong?
Education & Training
- University at BuffaloFellowship, Hematology and Medical Oncology, 2008 - 2009
- University at BuffaloFellowship, Hematology and Medical Oncology, 2006 - 2007
- Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2003 - 2006
- Maulana Azad Medical CollegeClass of 2000
Certifications & Licensure
- TX State Medical License 2009 - Present
- OH State Medical License 2003 - 2025
- FL State Medical License 2020 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma Start of enrollment: 2012 Dec 20
- NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma Start of enrollment: 2013 Jun 12
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin Lymphoma Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.Ozair, A., Rothrock, R. J., Robert J Rothrock, Ahmad Ozair, Maria C Avendano, Susana Herrera, Haley Appel, Suyen Ramos, Amy K Starosciak, Daniel S Leon-Ariza, Muni Rub...> ;Trials. 2024 Jan 12
- 2 citationsStable and Discriminatory Radiomic Features from the Tumor and Its Habitat Associated with Progression-Free Survival in Glioblastoma: A Multi-Institutional Study.R Verma, V B Hill, V Statsevych, K Bera, R Correa, P Leo, M Ahluwalia, A Madabhushi, P Tiwari> ;AJNR. American Journal of Neuroradiology. 2022 Aug 1
- Authorship diversity in global evidence synthesis in urology: 1998-2022 analysis of Cochrane reviews.Ahmad Ozair, Abhishek Kumar, Nishanth R Subash, Sahaam Mirza, Atulya A Khosla, Manmeet Ahluwalia, Philipp Dahm> ;BJU International. 2023 Jul 1
- Join now to see all
Journal Articles
- Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched ...Cosette Dechant, Gene H Barnett, Andreas Seas, Eric C Leuthardt, Kevin O Juarez, Hanna Kemeny, Peter E Fecci, Manmeet S Ahluwalia, Mayur Sharma, Thomas L Beaumont, Alb..., Neurosurgery
- Expression of LC3B and FIP200/Atg17 in Brain Metastases of Breast CancerManmeet S Ahluwalia, Lingling Du, Adam Lauko, Robert J Weil, Samuel T Chao, Journal of Neuro-Oncology
- Chapter 11 - Systemic Therapy for Brain MetastasesManmeet Ahluwalia, MD, ScienceDirect
Lectures
- SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.2019 ASCO Annual Meeting - 6/1/2019
- Effect of therapeutic pressure on stability of EGFR amplification in glioblastoma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Join now to see all
Authored Content
- First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
- First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
Press Mentions
- Cancer-Killing Virus plus Immunotherapy Boosts Survival in Aggressive Brain CancerMay 19th, 2023
- Baptist Health Is First in the State to Conduct Novel Liquid Biopsy in Brain Cancer PatientMarch 26th, 2023
- Cancer: Time of Day May Matter for Diagnosis, TreatmentMarch 24th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Baptist Hospital of MiamiMiami, Florida
- Cleveland ClinicCleveland, Ohio
- Cleveland Clinic Fairview HospitalCleveland, Ohio
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPOHealthAmerica HealthAssurance PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: